A C-Degron Structure-Based Approach for the Development of Ligands Targeting the E3 Ligase TRIM7
ACS Chemical Biology · 19.07.2024 · 19 (7) · 1638-1647
DOI: 10.1021/acschembio.4c00301 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 27.06.2024. Verfasst von Christian J Muñoz Sosa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe-University, Max-von-Laue-Straße 9, 60438 Frankfurt am Main, Germany. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Bundesministerium f??r Bildung und Forschung, Deutschen Konsortium f??r Translationale Krebsforschung, Structural Genomics Consortium.
Abstract (Originalsprache)
TRIM7 is a ubiquitin E3 ligase with key regulatory functions, mediating viral infection, tumor biology, innate immunity, and cellular processes, such as autophagy and ferroptosis. It contains a PRYSPRY domain that specifically recognizes degron sequences containing C-terminal glutamine. Ligands that bind to the TRIM7 PRYSPRY domain may have applications in the treatment of viral infections, as modulators of inflammation, and in the design of a new class of PROTACs (PROteolysis TArgeting Chimeras) that mediate the selective degradation of therapeutically relevant proteins (POIs). Here, we developed an assay toolbox for the comprehensive evaluation of TRIM7 ligands. Using TRIM7 degron sequences together with a structure-based design, we developed the first series of peptidomimetic ligands with low micromolar affinity. The terminal carboxylate moiety was required for ligand activity but prevented cell penetration. A prodrug strategy using an ethyl ester resulted in enhanced permeability, which was evaluated using confocal imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe-University, Max-von-Laue-Straße 9, 60438 Frankfurt am Main, Germany.
- Structural Genomics Consortium, Buchmann Institute for Life Sciences (BMLS), Johann Wolfgang Goethe-University, Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany.
- Enamine Ltd., Winston Churchill Street 78, 02094 Kyïv, Ukraine.
- Taras Shevchenko National University of Kyïv, Volodymyrska Street 60, Kyïv 01601, Ukraine.
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany.
ORCID-Profile: Christopher Lenz, Yurii S Moroz, Ewgenij Proschak, Václav Němec, Susanne Müller, Stefan Knapp
Förderung
- Bundesministerium f??r Bildung und Forschung
- Deutschen Konsortium f??r Translationale Krebsforschung
- Structural Genomics Consortium
Zitieren
APA
Muñoz Sosa, C. J., Lenz, C., Hamann, A., Farges, F., Dopfer, J., Krämer, A., Cherkashyna, V., Tarnovskiy, A., Moroz, Y. S., Proschak, E., Němec, V., Müller, S., Saxena, K., & Knapp, S. (2024). A C-Degron Structure-Based Approach for the Development of Ligands Targeting the E3 Ligase TRIM7. ACS Chemical Biology, 19(7), 1638-1647. https://doi.org/10.1021/acschembio.4c00301
Vancouver
Muñoz Sosa CJ, Lenz C, Hamann A, Farges F, Dopfer J, Krämer A, et al. A C-Degron Structure-Based Approach for the Development of Ligands Targeting the E3 Ligase TRIM7. ACS Chemical Biology. 2024;19(7):1638-1647. doi:10.1021/acschembio.4c00301
BibTeX
@article{MuozSosa2024,
author = {Muñoz Sosa, Christian J and Lenz, Christopher and Hamann, Anton and Farges, Frederic and Dopfer, Johannes and Krämer, Andreas and Cherkashyna, Veronika and Tarnovskiy, Andrey and Moroz, Yurii S and Proschak, Ewgenij and Němec, Václav and Müller, Susanne and Saxena, Krishna and Knapp, Stefan},
title = {A C-Degron Structure-Based Approach for the Development of Ligands Targeting the E3 Ligase TRIM7},
journal = {ACS Chemical Biology},
year = {2024},
volume = {19},
number = {7},
pages = {1638--1647},
doi = {10.1021/acschembio.4c00301}
}
EUVIMED